01 Ten milligrams, and only after the QT question
Ten milligrams is the Motilium tablet this leaf locks. Before anyone swallows it, the 2014 European review wants a cardiac screen in the history: conduction disease, heart failure, other QT-prolonging drugs, strong CYP3A4 inhibitors, severe hepatic impairment. Those are contraindications, not footnotes. Age over 60 and daily oral totals above 30 mg sat in the higher-risk group.
The FDA has not approved domperidone. Compounding and import for milk supply have a US warning history. This leaf will not invent a Motilium dollar or a GoodRx row. The fill strip says ask, not buy.
Metoclopramide is the US-labeled relative with more CNS movement. Domperidone stays out of the brain more, which is why people chase it for lactation and why cardiac risk became the European limiter. The QT margin and the lactation margin split those talks.
| Rule (EMA / MHRA era) | How this leaf uses it |
|---|---|
| 10 mg tablet | Virena lock; usual adult swallow |
| Up to 10 mg three times daily | Lowest effective, shortest time; nausea/vomiting only on the restricted EU indication |
| QT / cardiac disease / QT drugs / strong CYP3A4 inhibitors | Contraindicated in the 2014 European review |
| Lactation / milk supply | Not a licensed indication; FDA warns against US use and import |
| US retail cash | None. Not FDA-approved. No invented Motilium dollar |
02 Licensed nausea days are short; a quiet Tuesday is not a reason to extend
The 2014 European restriction moved the license toward nausea and vomiting, lowest effective dose, shortest time. Adult oral counseling settled on up to 10 mg three times daily. That is not a months-long dyspepsia hobby.
When the written days end, stop. Do not taper a seven-day nausea pack like a steroid. Do not extend it into a motility habit because the first quiet day felt good.
Fatty-meal hacks are the old advertising that review moved away from. If a gastroenterologist outside the US still writes a short course, they own the QT list. This leaf locks 10 mg as the tablet, not as a mealtime vitamin.
Metoclopramide is the US-labeled relative with more CNS movement. Switching stories belong to a clinician who can see both QT and tardive risk. Elise will not pick for you.
03 Nausea, lowest dose, shortest time
After the Europe-wide review, the indication narrowed to nausea and vomiting. Dyspepsia advertising and over-the-counter Motilium 10 in UK pharmacies went away. Prescription-only, medical assessment first. Adult oral counseling settled on up to 10 mg three times daily, shortest duration - often framed as about a week for the licensed symptom, not a months-long motility hobby.
This is not a US label. A traveler with a Belgian blister should still treat the QT line as live. A US reader with an internet pack should treat the whole product as unapproved, quality unknown.
Fainting, palpitations, or a seizure on the tablet is emergency care, not a second 10 mg. France: 15 or 112.
04 The ECG belongs before the first 10 mg, not after the first vomit
If someone in a licensed country is considering Motilium, the cardiac list comes first. Syncope history, known long QT, heart-failure clinic, other QT drugs, strong CYP3A4 inhibitors, severe liver disease, age over 60, family long-QT stories. Write them.
A year-old "fine" strip plus a new azole is stale. Assessment is current drugs. Starting 10 mg the night before an ECG inverts the order the QT margin exists to protect.
Palpitations, syncope, or a seizure: stop. France: 15 or 112. Tell the crew the INN. A pink European tablet is not a name.
Daily totals above 30 mg sat in the higher-risk group. 10 mg TID is already 30 mg. 20 mg TID is a different exposure and not a non-responder rescue for milk. See the lactation margin.
05 If you are in a country where Motilium 10 mg is licensed
Use it for nausea and vomiting, at the lowest effective dose, for the shortest time, after a cardiac check. Adult oral counseling in the 2014 review settled on up to 10 mg three times daily. That is not a months-long dyspepsia hobby and not a milk-supply license.
Swallow with the local SmPC's food rule. This leaf will not invent a US meal line. Space it from strong CYP3A4 inhibitors by not taking those inhibitors at all - they are contraindications, not spacing puzzles.
Stop for palpitations, syncope, or a seizure. France: 15 or 112. Tell the crew the INN, not "a pink European pill."
The QT margin is the list. The lactation margin is the claim-versus-safety file.
06 No US cash table, on purpose
Kroger and Safeway links on the strip are literacy, not stock. Domperidone is not a routine US retail tablet. Inventing a coupon would be a lie. If a US site sells Motilium, it is an import story with quality and legal risk, not a Virena fill.
| Pharmacy | Strength / count | Leaf note | Official page |
|---|---|---|---|
| Kroger | Ask Motilium 10 mg | Not an FDA-approved US tablet | Kroger desk |
| Safeway | Ask Motilium 10 mg | No invented Motilium coupon | Safeway desk |
| Harris Teeter | Ask Motilium 10 mg | Import lanes are outside US retail | Harris Teeter desk |
| Albertsons | Ask Motilium 10 mg | QT counseling still applies if sourced abroad | Albertsons desk |
07 If you are in the US with an internet blister
The FDA has not approved domperidone. Quality is unknown. This desk will not walk a how-to-take for an unapproved import. If you already swallowed one and you have cardiac symptoms, that is emergency care.
There is no honest US cash table. The fill strip says ask. Official US pharmacy links are literacy, not stock. Inventing a Motilium dollar would be a lie.
Compounding for milk supply has a US warning history. Do not treat a compounding jar as a licensed path. Lactation clinics start with latch and frequency.
Metoclopramide is the US-labeled relative with more CNS movement. Switching stories belong to a clinician who can see both QT and tardive risk. This leaf will not pick for you.
08 Do not add 10 mg because erythromycin made you nauseated
Erythromycin can raise domperidone and prolong QT. That pair is a double hit. Ask for another antiemetic with the person who wrote the macrolide. Do not borrow a cousin's Motilium for the waiting room.
Ketoconazole-type azoles are contraindications, not spacing puzzles. Grapefruit is a sloppy CYP3A inhibitor. Still a poor experiment beside a QT tablet.
Methadone, some antipsychotics, and some antidepressants already sit on QT lists. "Anyway" is the wrong word. Citalopram has its own QT story. Maybe is the wrong word until a clinician who sees both says otherwise.
If you are in the US, the FDA has not approved the INN. This desk will not walk a how-to-take for an unapproved import and will not invent a dollar.
09 Erythromycin, azoles, and the other QT tablet
Strong CYP3A4 inhibitors raise domperidone and are in the contraindication bucket. Some of those inhibitors also prolong QT. That is a double hit, not a subtle interaction. Erythromycin is the classic teaching pair.
Other antiemetics, some antipsychotics, some antidepressants, and methadone already sit on QT lists. Adding Motilium 10 mg "because metoclopramide caused restlessness" can be a worse cardiac trade. Ask for an ECG if the history is not empty.
Severe hepatic impairment is a stop. Renal impairment needs local SmPC caution; this leaf will not invent a US CrCl table.
| Absorption | Oral 10 mg; local SmPC for food. |
|---|---|
| Distribution | Peripheral D2 block; poor CNS penetration versus metoclopramide. |
| Metabolism | CYP3A4; inhibitor pairs are contraindicated in the EU restriction. |
| Excretion | Not a US PK monograph; do not copy a forum half-life as gospel. |
10 Build the list before the 10 mg
Age. Heart-failure clinic. Known long QT. Methadone. Some antipsychotics. Some antidepressants. Erythromycin. Ketoconazole-type azoles. Severe liver disease. Family long-QT stories. Write them. If the list is not empty, the 10 mg is the wrong tablet in the European restriction.
A year-old "fine" ECG plus a new azole is stale. Assessment is current drugs, not a souvenir strip.
Do not add 10 mg because metoclopramide caused restlessness. That trade can be a worse cardiac story.
Daily totals above 30 mg sat in the higher-risk group. 10 mg TID is already 30 mg. 20 mg TID is a different exposure and not a non-responder rescue for milk.
11 How to stop a 10 mg course that was already short
Licensed nausea courses are short. When the days end, stop. Do not taper a seven-day nausea pack like a steroid. Do not extend it into a motility hobby because the first quiet day felt good.
If someone wrote it off-label for supply, the stop date should have been written with the start. Weeks-to-months of 10 mg TID is a longer cardiac exposure than the EU nausea speech. Ask. Do not raise the tablet because a scale did not move.
12 Milk-supply claims sit beside the safety line, not above it
No country has a clean, official milk-supply license that this leaf can point to as a how-to-take. Studies that exist often used 10 mg three times daily for days, not 20 mg three times as a non-responder rescue. Higher daily totals track with more arrhythmia signal in observational work.
The FDA has warned breastfeeding people against importing or compounding domperidone for supply. LactMed repeats the unapproved US status. InfantRisk and similar desks discuss small average volume changes and a cardiac residual. None of that is a Bordeaux permission slip.
If a clinician outside the US still writes 10 mg for lactation, the QT history still comes first. This leaf will not time pumps around a tablet. Read the lactation margin for the claim-versus-safety file.
13 QT first, then nausea, then stop
If the tablet is 10 mg and the history is cardiac, the answer is not a second opinion from this site. If the goal is milk, the licensed European indication is not that goal. If the goal is a US pharmacy bag, this INN is not on the shelf.
Elise Moreau, 21 August 2026, Bordeaux. [email protected] for wording. No personal import advice.
Ten milligrams, QT questions first. Conduction disease, heart failure, other QT drugs, strong CYP3A4 inhibitors, and severe hepatic impairment are European contraindications. Age over 60 and daily oral totals above 30 mg sat in the higher-risk group. 10 mg three times daily is already 30 mg.
The FDA has not approved domperidone. There is no honest US cash table. Internet quality is unknown. This desk will not coach an import how-to-take. If you already swallowed one and you have palpitations or syncope, that is emergency care. France: 15 or 112.
Licensed European use after 2014 is nausea and vomiting, lowest dose, shortest time. Milk supply is not that path. Studies that measured volume often used 10 mg TID for days. Twenty milligrams TID did not reliably rescue non-responders. The QT margin and the lactation margin split those talks.
Erythromycin is the teaching double hit. Do not add 10 mg for macrolide nausea. Metoclopramide is the US-labeled relative with more CNS movement. Switching is a clinician list.
Mail [email protected] if we implied a US indication. We do not have one. Elise Moreau dated the bind 21 August 2026.
If the ECG is tomorrow, do not start 10 mg tonight to "cover" the waiting room. That inverts the order this leaf exists to protect. If vomiting is severe, they can choose a labeled antiemetic they know how to watch. A Belgian blister plus a US address does not pick the gentler paragraph.
Grapefruit is a sloppy CYP3A inhibitor beside a QT tablet. Still a poor experiment. Ketoconazole-type azoles are contraindications, not spacing puzzles. Do not add 10 mg because metoclopramide caused restlessness. That trade can be a worse cardiac story.